Some aspects of monoamine oxidase pharmacology.
D000818:Animals; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects / Q000201:enzymology; D008995:Monoamine Oxidase / Q000494:pharmacology*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects / Q000201:enzymology; D010080:Oxazoles / Q000494:pharmacology; D023303:Oxazolidinones; D051381:Rats; D012642:Selegiline / Q000494:pharmacology; D012663:Semicarbazides / Q000494:pharmacology; D014649:Vas Deferens / Q000187:drug effects / Q000201:enzymology
D008996:Monoamine Oxidase Inhibitors; D010080:Oxazoles; D023303:Oxazolidinones; D012663:Semicarbazides; D012642:Selegiline; C010059:carbamylhydrazine; D008995:Monoamine Oxidase; C026234:cimoxatone